Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Young-Joo Kim
Full-time employees:2291
City:Seoul
Address:8, Chungjeong-ro
IPO:2013-12-06
CIK:
Website:
General Outlook
When we look at how much money they make before expenses, they keep 0.530% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.146%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.122%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.144% return, is a testament to Chong Kun Dang Pharmaceutical Corp.'s adeptness in optimizing resource deployment. Chong Kun Dang Pharmaceutical Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.281%. Furthermore, the proficiency of Chong Kun Dang Pharmaceutical Corp. in capital utilization is underscored by a remarkable 0.271% return on capital employed.
Stock Prices
Chong Kun Dang Pharmaceutical Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $114500, while its low point bottomed out at $110600. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Chong Kun Dang Pharmaceutical Corp.'s stock market.
Liquidity Ratios
Analyzing 185750.KS liquidity ratios reveals its financial health of the firm.
The current ratio of 185.07% gauges short-term asset coverage for liabilities.
The quick ratio (132.27%) assesses immediate liquidity, while the cash ratio (42.94%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
185.07%
Quick Ratio
132.27%
Cash Ratio
42.94%
Profitability Ratios
185750.KS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 14.59% underscores its earnings before tax deductions.
The effective tax rate stands at 16.24%, revealing its tax efficiency.
The net income per EBT, 83.41%, and the EBT per EBIT, 100.00%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 14.59%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
14.59%
Effective Tax Rate
16.24%
Net Income per EBT
83.41%
EBT per EBIT
100.00%
EBIT per Revenue
14.59%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.85, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
132
Days of Inventory Outstanding
122
Operating Cycle
191.04
Days of Payables Outstanding
86
Cash Conversion Cycle
105
Receivables Turnover
5.32
Payables Turnover
4.24
Inventory Turnover
2.98
Fixed Asset Turnover
5.18
Asset Turnover
1.18
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 25007.33, and free cash flow per share, 19599.18, depict cash generation on a per-share basis.
The cash per share value, 28694.09, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.19, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
25007.33
Free Cash Flow per Share
19599.18
Cash per Share
28694.09
Operating Cash Flow Sales Ratio
0.19
Free Cash Flow to Operating Cash Flow Ratio
0.78
Cash Flow Coverage Ratio
1.48
Short Term Coverage Ratio
1.72
Capital Expenditure Coverage Ratio
4.62
Dividend Paid and Capex Coverage Ratio
4.62
Dividend Payout Ratio
0.01
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 15.31%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.26, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 3.55%, and total debt to capitalization, 20.84%, ratios shed light on its capital structure.
An interest coverage of 34.55 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
15.31%
Debt Equity Ratio
0.26
Long Term Debt to Capitalization
3.55%
Total Debt to Capitalization
20.84%
Interest Coverage
34.55
Cash Flow to Debt Ratio
1.48
Company Equity Multiplier
1.72
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 131214.98, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 16704.14, reflects the portion of profit attributed to each share.
The book value per share, 64113.48, represents the net asset value distributed per share, while the tangible book value per share, 59980.19, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
131214.98
Net Income Per Share
16704.14
Book Value Per Share
64113.48
Tangible Book Value Per Share
59980.19
Shareholders Equity Per Share
64113.48
Interest Debt Per Share
17609.38
Capex Per Share
-5408.15
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 12.17%, indicates top-line expansion, while the gross profit growth, 207.65%, reveals profitability trends.
EBIT growth, 124.37%, and operating income growth, 124.37%, offer insights into operational profitability progression.
The net income growth, 163.86%, showcases bottom-line expansion, and the EPS growth, 1997.24%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
12.17%
Gross Profit Growth
207.65%
EBIT Growth
124.37%
Operating Income Growth
124.37%
Net Income Growth
163.86%
EPS Growth
1997.24%
EPS Diluted Growth
-100.00%
Weighted Average Shares Growth
-100.00%
Weighted Average Shares Diluted Growth
-100.00%
Dividends per Share Growth
-100.00%
Operating Cash Flow Growth
-100.00%
Free Cash Flow Growth
-100.00%
10-Year Revenue Growth per Share
-100.00%
5-Year Revenue Growth per Share
-100.00%
3-Year Revenue Growth per Share
-100.00%
10-Year Operating CF Growth per Share
-100.00%
5-Year Operating CF Growth per Share
-100.00%
3-Year Operating CF Growth per Share
-100.00%
10-Year Net Income Growth per Share
-100.00%
5-Year Net Income Growth per Share
-100.00%
3-Year Net Income Growth per Share
-100.00%
10-Year Shareholders Equity Growth per Share
-100.00%
5-Year Shareholders Equity Growth per Share
-100.00%
3-Year Shareholders Equity Growth per Share
-100.00%
5-Year Dividend per Share Growth per Share
-100.00%
3-Year Dividend per Share Growth per Share
-100.00%
Receivables Growth
-100.00%
Inventory Growth
-100.00%
Asset Growth
24.67%
Book Value per Share Growth
-100.00%
Debt Growth
-100.00%
R&D Expense Growth
-100.00%
SGA Expenses Growth
-100.00%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,637,524,774,584, captures the company's total value, considering both debt and equity.
Income quality, 1.50, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 8.40%, highlights investment in innovation.
The ratio of intangibles to total assets, 3.75%, indicates the value of non-physical assets, and capex to operating cash flow, -21.63%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
1,637,524,774,584
Income Quality
1.50
Sales General and Administrative to Revenue
0.01
Research and Development to Revenue
8.40%
Intangibles to Total Assets
3.75%
Capex to Operating Cash Flow
-21.63%
Capex to Revenue
-4.12%
Capex to Depreciation
-186.25%
Graham Number
155230.82
Return on Tangible Assets
15.74%
Graham Net Net
11207.51
Working Capital
435,106,014,051
Tangible Asset Value
763,108,022,539
Net Current Asset Value
359,778,594,032
Average Receivables
299,387,614,086.5
Average Payables
164,687,512,701
Average Inventory
265,756,675,024
Days Sales Outstanding
68
Days Payables Outstanding
66
Days of Inventory On Hand
94
ROIC
21.16%
ROE
0.26%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.60, and the price to book ratio, 1.60, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 0.79, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 5.23, and price to operating cash flows, 4.10, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
1.60
Price to Book Ratio
1.60
Price to Sales Ratio
0.79
Price Cash Flow Ratio
4.10
Price Earnings to Growth Ratio
-0.05
Enterprise Value Multiple
2.93
Price Fair Value
1.60
Price to Operating Cash Flow Ratio
4.10
Price to Free Cash Flows Ratio
5.23
Price to Tangible Book Ratio
2.01
Enterprise Value to Sales
0.98
Enterprise Value Over EBITDA
5.77
EV to Operating Cash Flow
5.15
Earnings Yield
12.98%
Free Cash Flow Yield
15.23%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
